Related Experiment Video
Updated: Apr 7, 2026
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
Targeting cancer cell metabolism in pancreatic adenocarcinoma
Romain Cohen1, Cindy Neuzillet1,2, Annemilaï Tijeras-Raballand3
1INSERM U728, Beaujon University Hospital (AP-HP - PRES Paris 7 Diderot), Clichy La Garenne, France.
Abstract:
Pancreatic ductal adenocarcinoma (PDAC) is expected to become the second leading cause of cancer death by 2030. Current therapeutic options are limited, warranting an urgent need to explore innovative treatment strategies. Due to specific microenvironment constraints including an extensive desmoplastic stroma reaction, PDAC faces major metabolic challenges, principally hypoxia and nutrient deprivation. Their connection with oncogenic alterations such as KRAS mutations has brought metabolic reprogramming to the forefront of PDAC therapeutic research. The Warburg effect, glutamine addiction, and autophagy stand as the most important adaptive metabolic mechanisms of cancer cells themselves, however metabolic reprogramming is also an important feature of the tumor microenvironment, having a major impact on epigenetic reprogramming and tumor cell interactions with its complex stroma. We present a comprehensive overview of the main metabolic adaptations contributing to PDAC development and progression. A review of current and future therapies targeting this range of metabolic pathways is provided.
Insights
Pancreatic cancer (PDAC) shows significant metabolic challenges like hypoxia and nutrient deprivation. Targeting these metabolic adaptations offers promising new therapeutic strategies for this deadly disease.
Area of Science:
- Oncology
- Cancer Metabolism
- Tumor Microenvironment
Background:
- Pancreatic ductal adenocarcinoma (PDAC) is a deadly cancer with limited treatment options.
- PDAC is characterized by a challenging tumor microenvironment, including desmoplastic stroma, hypoxia, and nutrient deprivation.
- Metabolic reprogramming is crucial for PDAC development, progression, and therapeutic resistance.
Purpose of the Study:
- To provide a comprehensive overview of metabolic adaptations in PDAC.
- To review current and future therapies targeting PDAC metabolic pathways.
Main Methods:
- Literature review of metabolic adaptations in PDAC.
- Analysis of the role of metabolic reprogramming in PDAC development and progression.
- Review of therapeutic strategies targeting metabolic pathways in PDAC.
Main Results:
- Key metabolic adaptations in PDAC include the Warburg effect, glutamine addiction, and autophagy.
- Metabolic reprogramming impacts epigenetic changes and tumor-stroma interactions.
- The tumor microenvironment significantly influences PDAC cell metabolism.
Conclusions:
- Understanding PDAC metabolic reprogramming is vital for developing effective therapies.
- Targeting metabolic pathways presents a promising avenue for innovative PDAC treatment strategies.
- Further research into PDAC metabolism and therapeutic interventions is urgently needed.
More Related Videos
07:08Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:34Inhibition of Cdk Activity